Stealth Biotherapeutics Inc.

This study tests a daily shot called elamipretide to see if it can slow the loss of light-sensing cells in the eyes of people with dry age-related macular degeneration (AMD). About 313 adults aged 55 and older with early vision damage will receive either the drug or a placebo for…